Accelerating the Scale-Up of Voluntary Medical Male Circumcision for HIV Prevention for Maximum Public Health Impact in the United Republic of Tanzania under the President’s Emergency Plan for AIDS Relief (PEPFAR) | CDC RFA GH16 164702CONT17

Opportunity Information: Apply for CDC RFA GH16 164702CONT17

This funding opportunity, titled "Accelerating the Scale-Up of Voluntary Medical Male Circumcision for HIV Prevention for Maximum Public Health Impact in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR)," is a continuation cooperative agreement issued by the Centers for Disease Control and Prevention (CDC), specifically through CDC-CGH (Center for Global Health). The primary focus is public health: expanding and sustaining voluntary medical male circumcision (VMMC) services in Tanzania as a proven HIV prevention intervention supported under PEPFAR. The opportunity is not an open competition; it is explicitly intended to continue funding only for organizations that were previously awarded under the earlier related announcement CDC-RFA-GH16-1647. In practice, that means new applicants are not being solicited, and eligibility is limited to prior grantees already implementing this work.

The opportunity is categorized as "Continuation" funding and uses a "Cooperative Agreement" as the funding instrument. A cooperative agreement typically indicates that CDC expects to have substantial involvement in the funded activities, such as collaborative planning, technical guidance, performance monitoring, and coordination with national and partner stakeholders. The activity category is listed as Health, and the CFDA number is 93.067, which aligns with CDC global health and related assistance programming. The eligible applicant type is shown as "Others," but the description makes clear that, regardless of category, the only entities that can receive these continuation funds are the previously funded recipients from the predecessor award.

The goal implied by the title and description is to accelerate the scale-up of VMMC for maximum public health impact in Tanzania. VMMC is widely recognized in HIV prevention programming because clinical trials and real-world evidence have shown that it reduces the risk of female-to-male sexual transmission of HIV. In PEPFAR-supported contexts, scaling VMMC is often tied to achieving measurable reductions in new HIV infections, prioritizing geographic areas and populations with higher HIV incidence, and integrating services into broader prevention and treatment systems. While the posted notice does not provide a detailed scope of work, typical scale-up activities in such awards include increasing service delivery capacity, strengthening clinical quality and safety, ensuring adequate supply chains for commodities, improving demand creation and community engagement, supporting data collection and reporting, and coordinating with Tanzania's health authorities to align targets and implementation with national HIV strategies.

Several administrative details are provided in the source data. The funding opportunity number is CDC RFA GH16 164702CONT17, indicating it is a continuation action tied to the original GH16-1647 announcement. The original closing date is listed as 2017-03-31, and the creation date is 2017-02-02, which places this continuation action within the 2017 timeframe. The award ceiling is listed as 0, and the number of expected awards is not specified in the excerpt. In many government listings, a ceiling of 0 or blank fields can indicate that the precise funding levels are determined through internal continuation processes, depend on appropriations and annual planning, or are managed through existing award mechanisms rather than a newly competed pool with a published maximum.

Overall, this announcement functions as a formal notice that CDC intended to continue supporting existing implementers working on PEPFAR-backed VMMC scale-up in Tanzania, rather than launching a new competitive grant. The key takeaway is that it represents ongoing federal support to maintain momentum and expand impact of VMMC services as part of a broader HIV prevention strategy, with CDC providing funding and programmatic involvement through a cooperative agreement structure to previously selected partners.

• The Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Accelerating the Scale-Up of Voluntary Medical Male Circumcision for HIV Prevention for Maximum Public Health Impact in the United Republic of Tanzania under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on 2017-02-02.
• Applicants must submit their applications by 2017-03-31. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: Others.

Apply for CDC RFA GH16 164702CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: